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Model (RAM) for VTE. Medical records were reviewed for patients under-
going plastic surgery between March 2006 and June 2008. All patients with
Caprini scores 3 who had surgery under general anesthesia with postop-
erative hospital admission were included. Patients who received any form of
chemoprophylaxis were excluded. Outcomes of interest included symptom-
atic deep venous thrombosis (DVT) or pulmonary embolism (PE; confirmed
with imaging) 60 postoperative days.
Results: At present, 634 patients meeting inclusion criteria have been
identified. Mean Caprini score was 5.3. VTE occurred in 16 (2.52%; 8 DVT,
4 PE, 4DVT PE), with 25% of VTE occurring between postoperative days
30 and 60. Compared with those with Caprini scores of 3 to 4, VTE was
more likely to develop in patients with Caprini scores of 5 to 6 (odds ratio
[OR], 1.41; P  .654) and Caprini scores of 7 to 8 (OR 3.34; P  .119).
VTE was significantly more likely to develop in patients with Caprini scores
8 compared with those with Caprini scores of 3 or 4 (OR, 16.87, P 
.001), 5 or 6 (OR, 11.95, P  .001), and 7 or 8 (OR, 5.05; P  .022).
According to preoperative risk factors, the Caprini RAM categorized 13 of
16 patients (81%) who eventually developed VTE as “highest risk.” The
Caprini RAM has good discrimination for VTE in this patient population (c
statistic  0.679; Figs 1 and 2).
Conclusions: Plastic and reconstructive surgery patients are at
notable risk for perioperative VTE. The Caprini RAM demonstrates
acceptable validity in identifying those patients at greatest risk. Patients
with a Caprini score  8 are at significantly increased risk to develop
VTE. A separate “maximum” risk level may be warranted for these
patients in future RAMs.
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Background: Chronic venous hypertension causes skin damage. Ex-
ternal leg compression, therefore, is the logical treatment. In venous ulcer-
ation, however, secondary phenomena (eg, chronic inflammation caused by
iron overload and toxicity) may attain a crucial role and render high-pressure
bandaging unfavorable.
Methods: Assessment was conducted of eventual associations between
patient characteristics, ulcer features, and strength of compression and
success of healing with the intention to identify risk factors that might
require treatment modification.
Results: Data were gathered from 99 patients taking part in trials
comparing various types of compression. Patients were grouped according
to compression strength measured in representative subsets. The moderate-
compression group included 41 patients (all treated with stockings exerting
15 to 30 mm Hg to the ulcer area), the high-strength group comprised 58
patients (9 treated with stockings 35 mm Hg and 49 with bandages 40
mm Hg). Significant associations (P  .05) were identified between poten-
tial risk factors and nonhealing or healing90 days, respectively: patient age
(66 vs 57 years), body mass index (30 vs 33 kg/m2), presence of hemochro-
matosis single nucleotide polymorphism (SNP) HFE H63D (38% vs 19%),
SNP of coagulation factor FXIII V34L (56% vs 35%), deep venous reflux
(50% vs 26%), time of ulcer presence (42 vs 11 months), and ulcer surface
(27 vs 4.5 cm2). Sex, recurrent ulcer, edema and pain, and strength of
compression showed no association with healing. After multivariate analysis,
patient age, time of ulcer presence, and size remained the only significant
determinants of nonhealing (P  .018, P  .037, and P  .001, respec-
tively). Two-way analysis of variance of compression and risk factors showed
an interaction effect between compression and HFE H63D: ulcer healing
13% (2 of 5) in carriers of HFE H63D (prevalence 29%) treated with
high-strength compression compared with 42% of 50 carriers treated with
moderate strength and wild-type patients treated with strength or compres-
sion (50%; P  .008).
Conclusions: Of the many factors connected with poor healing of
venous leg ulcers only one emerged as possibly relevant for treatment:
carriers of SNPHFEH63D are at high risk of nonhealing when treatment is
performed with high-strength instead of moderate-strength compression.
The finding is of particular importance because the prevalence of this genetic
variant is high in ulcer patients.
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Background: Iliocaval venous obstruction (ICVO) can be a significant
contributor to venous hypertension in patients with advanced disease.
Percutaneous stenting has been reported to correct ICVO, resulting in
improvement in pain, swelling, and other venous symptoms. The incidence
of ICVO in patients with CEAP clinical class 5 and 6 disease has not been
reported. In this study, we reviewed a series of patients with healed or active
venous leg ulcers to determine the incidence of ICVO and the risk factors
related to its occurrence.
Methods: Patients with CEAP clinical class 5 and 6 venous insuffi-
ciency underwent routine evaluation with duplex ultrasound imaging to
identify the presence of venous reflux in the deep and superficial systems.
Computed tomography (CT) or magnetic resonance (MR) venography was
performed in all patients. Each study was evaluated by two separate exam-
iners to determine the percentage of obstruction in the iliocaval outflow
tract. Demographics and risk factors related to venous disease were collected
and examined for their association with the presence of ICVO.
Results: We retrospectively reviewed 78 CEAP clinical class 5 and 6
patients (53.4% men; average age, 59.3 years) evaluated with a CT or MR
venogram. The ulcer affected the left lower extremity in 46%, and 50%
reported a history of deep vein thrombosis (DVT). Duplex ultrasound
imaging identified deep venous reflux (DVR) only in 13% of ulcerated limbs,
superficial venous reflux (SVR) only in 38%, and combined DVR and SVR in
49%. The incidence of iliac and IVC obstruction is listed in the Table.
Overall, 37% of imaging studies demonstrated ICVO of at least 50%. Risk
factors that were associated with a significantly higher incidence of 80%
narrowing of the iliocaval outflow tract included a history of DVT (P 
.005) and reflux in the deep venous system (P  .002). No limb with SVR
alone was found to have ICVO  80%. Although high-grade ICVO oc-
curred more frequently in women and in patients with left leg ulcers, the
frequency was not statistically significance.
Fig 1. Caprini scores among 634 plastic surgery patients
Fig 2. Percentage of patients with venous thromboembolism
(VTE) by Caprini score.
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Conclusions: ICVO is a frequent and under-appreciated contributor
to venous hypertension in patients with venous leg ulcers. Patients with a
history of DVT or duplex-diagnosed DVR have a higher incidence of
outflow obstruction and should be routinely studied with CT or MR
venography to allow correction in this high-risk group of patients.
Table. Incidence of iliocaval stenosis in all cases and in
limbs with prior deep vein thrombosis (DVT) or deep
venous reflux (DVR)
Iliocaval stenosis Total cases, % DVT history, % DVR, %
100% 8.8 17.2 18.3
80% to 99% 14 20.7 21.5
50% to 79% 14 13.8 12.3
30% to 49% 5.3 3.4 5.1
10% to 29% 17.5 13.8 11.8
10% 42.1 31 30.8
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Background: Stenting was recognized as the method of choice for
treatment of femoroiliac veins obstructive disease. We report the experience
of three European centers in the endovascular treatment of post-thrombotic
obstructive lesions, which are recognized as the most challenging.
Methods: From January 1996 to July 2009, 130 limbs in 109 consec-
utive patients (66 women; median age, 44 years; thrombophilia, 28 patients)
were admitted for endovascular treatment of nonmalignant post-deep vein
thrombosis (DVT) iliac veins obstructive disease. Limbs were classified
CEAP C1 in 1 limb, C2 in 1, C3 in 42, C4 in 28, C5 in 11, and C6 in 47. All
patients were symptomatic and disabled despite medical treatment, includ-
ing 49 with venous claudication. Median delay since DVT was 12 years.
Lesions were bilateral in 21 patients. The inferior vena cava (IVC) was
involved in 21 cases and the common femoral vein in 33; moreover, 80 limbs
(61%) had at least one occluded venous segment. Four IVC filters and two
IVC clips were in place. The endovascular procedure was performed through
percutaneous access of the femoral vein. Recanalization was performedwhen
needed; then, self-expanding stents were deployed.
Results: Sixty-three patients had general anesthesia, and 46 had local
anesthesia, associated with sedation in 44 cases. Recanalization failed in 22
limbs (15 patients), and the procedure was stopped. Moreover, recanaliza-
tion failed in three limbs, but the ipsilateral ascending lumbar vein was
stented. A total of 181 stents were deployed to treat 149 venous segments.
One IVC clip was removed. No perioperative death or pulmonary embolism
occurred. One superficial femoral artery tear was treated with a stent graft.
Postoperative complications included four early rethrombosis (3 had left
iliac vein recanalization with common femoral vein involvement and 3 were
successfully treated by venous thrombectomy), one right hemothorax, and
two hematomas. Median length of stay was 3 days (range, 1-14 days).
During a median 27 months’ follow-up (range, 1-157 months), one patient
died at 18 months, four symptomatic restenosis needed iterative endovas-
cular procedure, and five late rethrombosis were diagnosed (2 had successful
venous thrombectomy). Moreover, one patient with contralateral femo-
roiliac DVT was successfully treated by venous thrombectomy. Primary,
assisted primary, and secondary patency rates in intention to treat were,
respectively, 76%, 77%, and 80% at 1 year, and 66%, 70%, and 77% at 5 and
10 years (90%, 91%, and 93% at 1 year, and 77%, 82%, and 86% at 10 years
in case of technical success). All C6 limbs but two had healed at the end of the
follow-up.
Conclusions: Late results confirm that stenting is a safe and effective
technique. It is also a durable way to treat post-thrombotic obstructive
disease in iliac veins.
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Background: Electrostimulation of calf muscles has been shown to be
effective in prevention of deep venous thrombosis (DVT). Nevertheless, the
stimulation rates needed to obtain optimal hemodynamic effects for prevent-
ing venous stasis have not yet been investigated. The goal of this study was
to determine (1) dependence of venous blood velocity and ejected volume
on the rates of stimulated calf contractions and (2) clinical factors that affect
efficacy.
Methods: The maximum intensity stimulus that can be tolerated
comfortably was applied to calves of 12 healthy volunteers. In popliteal
veins, peak velocities (PV) and total volume flow (TVF) of expelled blood
were determined using duplex Doppler imaging. Eleven stimulation rates: 2,
3, 4, 6, 7.5, 10, 15, 20, 30, 60, and 120 beats/min were applied using Food
and Drug Administration- and Conformite´ Europe´ene-registered VEINO-
PLUS devices.
Results: PV decreased and TVF increased with increasing rate of
stimulation. The mean and 95% confidence interval of the PV and TVF
measurements obtained at 5, 60 and 120 beats/min are shown in the Fig.
The rates of stimulation resulting in highest mean TVF were 60 and 120
beats/min. They showed an increase of TVF equal to 7 times baseline. In
addition, there were simultaneous increases of mean PV equal to 5 times
baseline at a rate of 60 and 4 times baseline at a rate of 120. The stimulation
rate of 5 beats/min produced highest mean PV of 11 times baseline yet
resulted in only a small increase of mean TVF (2 times baseline). The PV
and TVF were approximately 40% lower in women and were 30% lower in
volunteers aged older than50 years, those with calf circumference37cm,
and/or in those with popliteal vein diameter 0.87cm. Logistic regression
with PV as the dependent variable found the following clinical factors
remained significant: rate (P  .001), age (P  .001), gender (P  .001),
calf circumference (P  .003), and popliteal vein lumen diameter (P 
.005).
Conclusions: VEINOPLUS stimulation is an effective method of
activating the calf muscle pump. The enhancements of popliteal blood
velocity and volume flow, as shown by this study, are key factors in the
prevention of venous stasis and DVT. Further studies are justified to deter-
mine the rates and configurations of stimulation, which are applicable in
presence or absence of clinical factors and venous reflux, which influence calf
pump output.
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Background: Patients with iliofemoral deep venous thrombosis
(DVT) are at highest risk for post-thrombotic morbidity, including the
post-thrombotic syndrome. Invasive therapies such as catheter-directed
thrombolysis (CDL), thrombectomy with or without balloon angioplasty,
and stenting improves venous patency, venous valve function, and quality of
life in patients with acute iliofemoral DVT.What is the current prevalence of
acute iliofemoral DVT and how aggressively is it being treated? We hypoth-
esized that the 10-year period prevalence of iliofemoral DVT among acute
DVT cases is greater than previously reported and that thrombus removal to
treat acute iliofemoral DVT is little utilized in current practice.
Methods: Indiana University (IU) vascular laboratory records from
January 1, 1998, to December 31, 2008, were searched by Current Proce-
dural Terminology code for venous Doppler ultrasound study (n  7240).
A random sample of 750 patients based on the number in IUmedical record
of lower extremity Doppler studies was then selected for retrospective record
review. Corresponding clinical information was gathered from the patients’
electronic medical record in Cerner PowerChart.
Fig. Peak velocity (PV) and total volume flow (TVF) vs rate of
stimulation.
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